vs

Side-by-side financial comparison of HARTE HANKS INC (HHS) and indie Semiconductor, Inc. (INDI). Click either name above to swap in a different company.

indie Semiconductor, Inc. is the larger business by last-quarter revenue ($58.0M vs $39.9M, roughly 1.5× HARTE HANKS INC). HARTE HANKS INC runs the higher net margin — 5.5% vs -53.8%, a 59.4% gap on every dollar of revenue. On growth, indie Semiconductor, Inc. posted the faster year-over-year revenue change (-0.0% vs -15.4%). HARTE HANKS INC produced more free cash flow last quarter ($-686.0K vs $-16.1M). Over the past eight quarters, indie Semiconductor, Inc.'s revenue compounded faster (5.3% CAGR vs -6.4%).

Harte Hanks is a global marketing services company headquartered in Boston, Massachusetts. Harte Hanks services include analytics, strategy, marketing technology, creative services, digital marketing, customer care, direct mail, logistics, and fulfillment.

indie Semiconductor is a fabless semiconductor manufacturer focused on designing high-performance mixed-signal and embedded system-on-chip solutions for the automotive industry. Its products support advanced driver assistance systems, in-vehicle infotainment, connected car, and electric vehicle applications, serving global auto OEMs and tier 1 suppliers across major global markets.

HHS vs INDI — Head-to-Head

Bigger by revenue
INDI
INDI
1.5× larger
INDI
$58.0M
$39.9M
HHS
Growing faster (revenue YoY)
INDI
INDI
+15.4% gap
INDI
-0.0%
-15.4%
HHS
Higher net margin
HHS
HHS
59.4% more per $
HHS
5.5%
-53.8%
INDI
More free cash flow
HHS
HHS
$15.4M more FCF
HHS
$-686.0K
$-16.1M
INDI
Faster 2-yr revenue CAGR
INDI
INDI
Annualised
INDI
5.3%
-6.4%
HHS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HHS
HHS
INDI
INDI
Revenue
$39.9M
$58.0M
Net Profit
$2.2M
$-31.2M
Gross Margin
37.3%
Operating Margin
-0.3%
-58.5%
Net Margin
5.5%
-53.8%
Revenue YoY
-15.4%
-0.0%
Net Profit YoY
9.1%
EPS (diluted)
$0.30
$-0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HHS
HHS
INDI
INDI
Q4 25
$39.9M
$58.0M
Q3 25
$39.5M
$53.7M
Q2 25
$38.6M
$51.6M
Q1 25
$41.6M
$54.1M
Q4 24
$47.1M
$58.0M
Q3 24
$47.6M
$54.0M
Q2 24
$45.0M
$52.4M
Q1 24
$45.4M
$52.4M
Net Profit
HHS
HHS
INDI
INDI
Q4 25
$2.2M
$-31.2M
Q3 25
$-2.3M
$-38.3M
Q2 25
$-335.0K
$-39.0M
Q1 25
$-392.0K
$-34.5M
Q4 24
$-34.4M
Q3 24
$142.0K
$-49.7M
Q2 24
$-27.8M
$-19.2M
Q1 24
$-171.0K
$-31.2M
Gross Margin
HHS
HHS
INDI
INDI
Q4 25
37.3%
Q3 25
40.1%
Q2 25
40.6%
Q1 25
41.7%
Q4 24
42.6%
Q3 24
39.3%
Q2 24
42.2%
Q1 24
42.5%
Operating Margin
HHS
HHS
INDI
INDI
Q4 25
-0.3%
-58.5%
Q3 25
1.3%
-71.4%
Q2 25
0.1%
-83.3%
Q1 25
-0.1%
-72.0%
Q4 24
-3.3%
-58.4%
Q3 24
4.0%
-92.5%
Q2 24
3.0%
-70.0%
Q1 24
0.8%
-94.8%
Net Margin
HHS
HHS
INDI
INDI
Q4 25
5.5%
-53.8%
Q3 25
-5.8%
-71.3%
Q2 25
-0.9%
-75.6%
Q1 25
-0.9%
-63.9%
Q4 24
-59.2%
Q3 24
0.3%
-92.1%
Q2 24
-61.8%
-36.6%
Q1 24
-0.4%
-59.6%
EPS (diluted)
HHS
HHS
INDI
INDI
Q4 25
$0.30
$-0.16
Q3 25
$-0.31
$-0.19
Q2 25
$-0.05
$-0.20
Q1 25
$-0.05
$-0.18
Q4 24
$-0.31
$-0.18
Q3 24
$0.02
$-0.28
Q2 24
$-3.84
$-0.11
Q1 24
$-0.02
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HHS
HHS
INDI
INDI
Cash + ST InvestmentsLiquidity on hand
$5.6M
$145.5M
Total DebtLower is stronger
$353.4M
Stockholders' EquityBook value
$20.5M
$358.0M
Total Assets
$91.8M
$840.8M
Debt / EquityLower = less leverage
0.99×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HHS
HHS
INDI
INDI
Q4 25
$5.6M
$145.5M
Q3 25
$6.5M
$160.9M
Q2 25
$4.8M
$192.6M
Q1 25
$9.0M
$236.6M
Q4 24
$9.8M
$274.2M
Q3 24
$5.9M
$96.9M
Q2 24
$11.0M
$112.3M
Q1 24
$11.5M
$138.2M
Total Debt
HHS
HHS
INDI
INDI
Q4 25
$353.4M
Q3 25
$353.5M
Q2 25
$352.5M
Q1 25
$379.0M
Q4 24
$381.3M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
HHS
HHS
INDI
INDI
Q4 25
$20.5M
$358.0M
Q3 25
$19.9M
$369.2M
Q2 25
$22.2M
$390.4M
Q1 25
$21.4M
$405.6M
Q4 24
$21.7M
$417.9M
Q3 24
$21.0M
$458.6M
Q2 24
$20.6M
$470.7M
Q1 24
$20.0M
$432.9M
Total Assets
HHS
HHS
INDI
INDI
Q4 25
$91.8M
$840.8M
Q3 25
$92.7M
$855.1M
Q2 25
$95.0M
$867.6M
Q1 25
$100.6M
$909.0M
Q4 24
$101.8M
$941.4M
Q3 24
$108.1M
$797.5M
Q2 24
$109.7M
$797.3M
Q1 24
$113.4M
$803.6M
Debt / Equity
HHS
HHS
INDI
INDI
Q4 25
0.99×
Q3 25
0.96×
Q2 25
0.90×
Q1 25
0.93×
Q4 24
0.91×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HHS
HHS
INDI
INDI
Operating Cash FlowLast quarter
$737.0K
$-14.4M
Free Cash FlowOCF − Capex
$-686.0K
$-16.1M
FCF MarginFCF / Revenue
-1.7%
-27.8%
Capex IntensityCapex / Revenue
3.6%
3.0%
Cash ConversionOCF / Net Profit
0.33×
TTM Free Cash FlowTrailing 4 quarters
$-4.5M
$-71.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HHS
HHS
INDI
INDI
Q4 25
$737.0K
$-14.4M
Q3 25
$3.2M
$-6.2M
Q2 25
$-4.8M
$-7.6M
Q1 25
$-818.0K
$-29.0M
Q4 24
$4.0M
$-6.7M
Q3 24
$-2.9M
$-22.8M
Q2 24
$1.6M
$-19.7M
Q1 24
$-5.7M
$-9.3M
Free Cash Flow
HHS
HHS
INDI
INDI
Q4 25
$-686.0K
$-16.1M
Q3 25
$2.2M
$-10.3M
Q2 25
$-5.1M
$-13.6M
Q1 25
$-923.0K
$-31.4M
Q4 24
$3.4M
$-8.6M
Q3 24
$-4.9M
$-29.3M
Q2 24
$926.0K
$-23.4M
Q1 24
$-6.2M
$-11.7M
FCF Margin
HHS
HHS
INDI
INDI
Q4 25
-1.7%
-27.8%
Q3 25
5.5%
-19.2%
Q2 25
-13.1%
-26.4%
Q1 25
-2.2%
-58.0%
Q4 24
7.3%
-14.8%
Q3 24
-10.2%
-54.3%
Q2 24
2.1%
-44.7%
Q1 24
-13.7%
-22.3%
Capex Intensity
HHS
HHS
INDI
INDI
Q4 25
3.6%
3.0%
Q3 25
2.5%
7.8%
Q2 25
0.6%
11.6%
Q1 25
0.3%
4.4%
Q4 24
1.3%
3.2%
Q3 24
4.0%
12.1%
Q2 24
1.5%
7.0%
Q1 24
1.2%
4.4%
Cash Conversion
HHS
HHS
INDI
INDI
Q4 25
0.33×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
-20.76×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HHS
HHS

Fulfillment And Logistics Services$17.3M43%
Customer Care$13.7M34%
Other$8.9M22%

INDI
INDI

Products$55.7M96%
Services$2.3M4%

Related Comparisons